The progress of mankind is due exclusively to the progress of natural sciences, not to morals, religion or philosophy.

Justus von Liebig, 1866



OCS-2009    |    GEOHET-2011


Prof. Horst Kunz

Professor emeritus of Organic and Bioorganic Chemistry

Address Institut fuer Organische Chemie
Johannes Gutenberg-Universitaet Mainz
Duesbergweg 10-14
D - 55099 Mainz, Germany,



Date/Place of Birth:
 December 3rd, 1940, Frankenhausen, Distr. Zwickau, Saxony, Germany

Academic Education

  •  1961 Humboldt Universitaet, Berlin
  • 1962 - 1969 Universitaet Mainz

Dr. rer. nat. (PhD)
 1969 Thesis on organophosphorus chemistry (Supervisor Professor Leopold Horner), Universitaet Mainz

1977 "The alkaline hydrolysis of esters analogous to acetylcholine and its application in protecting group chemistry"

Academic Positions

  •  1978 Associate Professor, Universitaet Mainz
  • 1988 Full Professor (Chair) at Universitaet Mainz

Academic Distinctions

  • 1992 Max-Bergmann-Medal
  • 1995 Guest Professor, University Paris-Sud, Orsay, France
  • 1995 Sandoz Foundation Lecture, Regensburg, Germany
  • 1998 Member of the Saxony Academy of Science
  • 1999 Novartis Lectureship in: Basel, Wien, Horsham, Summit
  • 2000 Emil-Fischer-Medal
  • 2001 Adolf-Windaus-Medal of the Universitaet Goettingen


Research Interests

Preparative Organic Chemistry, Natural Products, Carbohydrate Chemistry, Peptide Chemistry, Glycopeptide Synthesis, Stereoselective Synthesis, Combinatorial Chemistry.

Some Recent Publications

Stereoselective synthesis of enantiomerically pure nupharamine alkaloids from Castoreum

A. Stoye, G.Quandt, B. Brunnhöfer, E. Kapatsina, J. Baron, A. Fischer, M. Weymann, H. Kunz, Angew. Chem. 2009, 121, 2262-2264; Angew. Chem. Int. Ed. 2009, 48, 2228-2230.

A synthetic vaccine consisting of a tumor-associated Sialyl-Tn-MUC1 tandem repeat glycopeptide and Tetanus-Toxoid: induction of a strong highly selective immune response

A. Kaiser, N. Gaidzik, U. Westerlind, D. Kowalczyk, A. Hobel, E. Schmitt, H. Kunz, Angew. Chem. Int. Ed. 2009, 48, 7551-7555.

Synthetic antitumor vaccine containig MUC1 glycopeptides with two immundominant domains – induction of a strong immune response against breast tumor tissues

N. Gaidzik, A. Kaiser, D. Kowalczyk, U. Westerlind, B. Gerlitzki, H. P. Sinn, E. Schmitt, H. Kunz, Angew. Chem. 123 (2011), 10153-7; Angew. Chem. Int. Ed. 2011, 50,9977-9981.

The development of synthetic antitumor vaccines from mucin glycopeptide antigens. N. Gaidzik, U. Westerlind, H. Kunz, Chem. Soc. Rev. 2013, 42, 4421–4442